1. Home
  2. SMTI vs NCV Comparison

SMTI vs NCV Comparison

Compare SMTI & NCV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

N/A

Current Price

$32.21

Market Cap

322.2M

Sector

Health Care

ML Signal

N/A

Logo Virtus Convertible & Income Fund of Beneficial Interest

NCV

Virtus Convertible & Income Fund of Beneficial Interest

N/A

Current Price

$14.87

Market Cap

337.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SMTI
NCV
Founded
1982
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
322.2M
337.1M
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
SMTI
NCV
Price
$32.21
$14.87
Analyst Decision
Hold
Analyst Count
3
0
Target Price
★ $35.00
N/A
AVG Volume (30 Days)
★ 113.7K
61.3K
Earning Date
11-20-2026
01-01-0001
Dividend Yield
N/A
★ 12.48%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $15,586,976.00
N/A
Revenue This Year
$13.07
N/A
Revenue Next Year
$14.23
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 32.47
N/A
52 Week Low
$16.05
$14.46
52 Week High
$35.52
$17.65

Technical Indicators

Market Signals
Indicator
SMTI
NCV
Relative Strength Index (RSI) 35.41 43.36
Support Level $30.40 $14.46
Resistance Level $34.36 $16.73
Average True Range (ATR) 0.95 0.31
MACD -0.09 -0.01
Stochastic Oscillator 68.77 33.84

Price Performance

Historical Comparison
SMTI
NCV

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

About NCV Virtus Convertible & Income Fund of Beneficial Interest

Virtus Convertible & Income Fund is a diversified, closed-end management investment company. Its investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. It intends to achieve the objective by investing in a portfolio of domestic convertible securities and non-convertible income-producing securities. Its portfolio of investments includes Software, the Internet, the Commercial Services sector in the form of Convertible Bonds and Notes, and Media, Oil, Gas & Consumable Fuels, and Entertainment sector in the form of Corporate Bonds and Notes.

Share on Social Networks: